Tag: rvl pharmaceuticals

All

RVL Pharmaceuticals reported 22% revenue growth for Upneeq in Q3 2025 and announced leadership changes to support continued expansion of the product.

The Clear + Brilliant Touch laser, cleared by the FDA in 2022, includes two wavelengths designed to address wrinkles, pigmentation, and skin texture.